Methods used for mock survey for external quality control specimens for hepatitis viral antigen and antibody assessment
| Year and trial | Method | Instruments, manufacturers |
|---|---|---|
| 2018-1st & 2nd trial | ECLIA | Cobas e602 modules/E170, Roche |
| CLIA | Architect i2000, Abbott | |
| Centaur XP/XPT, Siemens Healthcare | ||
| UniCel DxI 800, Beckman Coulter | ||
| EciQ, Ortho-Clinical Diagnostics | ||
| FEIA | VIDAS, BioMérieux | |
| 2019-1st & 2nd trial | ECLIA | Cobas e602, e801 modules/E170, Roche |
| CLIA | Architect i2000/Alinity i, Abbott | |
| Centaur XP/Atellica IM, Siemens Healthcare | ||
| UniCel DxI 800, Beckman Coulter | ||
| EciQ, Ortho-Clinical Diagnostics | ||
| Centaur XP/Atellica IM, Siemens Healthcare | ||
| FEIA | VIDAS, BioMérieux |
The following instruments were used: Cobas e602/e801 modules, E170 (Roche Diagnostics GmbH, Mannheim, Germany), Architect i2000, Alinity i (Abbott Diagnostics, Abbott Park, IL, USA), Centaur XP/XPT, Atellica IM (Siemens Healthineers, Erlangen, Germany), UniCel DxI 800 (Beckman Coulter Inc., Brea, CA, USA), EciQ (Ortho Clinical Diagnostics, Raritan, NJ, USA), and VIDAS (BioMérieux, Marcy-L'Etoile, France).
Abbreviations: ECLIA, electrochemiluminescence immunoassay; CLIA, chemiluminescence immunoassay; FEIA, fluorescence enzyme immunoassay.